• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素抑制垂体腺瘤中 HIF1A 的合成和 VEGFA 的释放。

Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas.

机构信息

Neuroendocrinology Group, Max Planck Institute of Psychiatry, Kraepelinstraße 10, D-80804 Munich, Germany.

出版信息

J Endocrinol. 2012 Sep;214(3):389-98. doi: 10.1530/JOE-12-0207. Epub 2012 Jun 27.

DOI:10.1530/JOE-12-0207
PMID:22739211
Abstract

Curcumin (diferuloylmethane), a polyphenolic compound derived from the spice plant Curcuma longa, displays multiple actions on solid tumours including anti-angiogenic effects. Here we have studied in rodent and human pituitary tumour cells the influence of curcumin on the production of hypoxia inducible factor 1α (HIF1A) and vascular endothelial growth factor A (VEGFA), two key components involved in tumour neovascularisation through angiogenesis. Curcumin dose-dependently inhibited basal VEGFA secretion in corticotroph AtT20 mouse and lactosomatotroph GH3 rat pituitary tumour cells as well as in all human pituitary adenoma cell cultures (n=32) studied. Under hypoxia-mimicking conditions (CoCl(2) treatment) in AtT20 and GH3 cells as well as in all human pituitary adenoma cell cultures (n=8) studied, curcumin strongly suppressed the induction of mRNA synthesis and protein production of HIF1A, the regulated subunit of the hypoxia-induced transcription factor HIF1. Curcumin also blocked hypoxia-induced mRNA synthesis and secretion of VEGFA in GH3 cells and in all human pituitary adenoma cell cultures investigated (n=18). Thus, curcumin may inhibit pituitary adenoma progression not only through previously demonstrated anti-proliferative and pro-apoptotic actions but also by its suppressive effects on pituitary tumour neovascularisation.

摘要

姜黄素(双阿魏酰甲烷),一种来源于香料植物姜黄的多酚化合物,对实体瘤具有多种作用,包括抗血管生成作用。在这里,我们研究了姜黄素对缺氧诱导因子 1α(HIF1A)和血管内皮生长因子 A(VEGFA)产生的影响,这两种因子是通过血管生成参与肿瘤新生血管形成的关键成分。姜黄素在不同剂量下可抑制促皮质素 AtT20 小鼠和生长激素 GH3 大鼠垂体肿瘤细胞以及所有研究的人类垂体腺瘤细胞培养物(n=32)中的基础 VEGFA 分泌。在 AtT20 和 GH3 细胞以及所有研究的人类垂体腺瘤细胞培养物(n=8)中模拟缺氧条件(CoCl2 处理)下,姜黄素强烈抑制 HIF1A(缺氧诱导转录因子 HIF1 的调节亚基)的 mRNA 合成和蛋白产生的诱导。姜黄素还阻断了 GH3 细胞和所有研究的人类垂体腺瘤细胞培养物(n=18)中缺氧诱导的 VEGFA mRNA 合成和分泌。因此,姜黄素不仅可以通过先前证明的抗增殖和促凋亡作用,还可以通过抑制垂体肿瘤新生血管生成来抑制垂体腺瘤的进展。

相似文献

1
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas.姜黄素抑制垂体腺瘤中 HIF1A 的合成和 VEGFA 的释放。
J Endocrinol. 2012 Sep;214(3):389-98. doi: 10.1530/JOE-12-0207. Epub 2012 Jun 27.
2
Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo.姜黄素在体外和体内的鼠类和人类垂体肿瘤细胞中作为抗肿瘤和激素抑制因子发挥作用。
Endocr Relat Cancer. 2009 Dec;16(4):1339-50. doi: 10.1677/ERC-09-0129. Epub 2009 Sep 2.
3
Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells.姜黄素抑制垂体细胞生长、诱导其凋亡并调节其功能。
Neuroendocrinology. 2010;91(2):200-10. doi: 10.1159/000287236. Epub 2010 Feb 17.
4
Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.姜黄素通过下调缺氧诱导因子-1(HIF-1)来抑制缺氧诱导的血管生成。
Oncol Rep. 2006 Jun;15(6):1557-62.
5
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.RSUME 被牵连到了 HIF-1 诱导的脑垂体肿瘤细胞中 VEGF-A 的产生。
Endocr Relat Cancer. 2012 Jan 9;19(1):13-27. doi: 10.1530/ERC-11-0211. Print 2012 Feb.
6
Hypoxia induces hemorrhagic transformation in pituitary adenomas via the HIF-1α signaling pathway.缺氧通过 HIF-1α 信号通路诱导垂体腺瘤发生出血性转化。
Oncol Rep. 2011 Dec;26(6):1457-64. doi: 10.3892/or.2011.1416. Epub 2011 Aug 5.
7
Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells.血小板衍生生长因子(PDGF)及其受体在滤泡星状垂体细胞中的表达与功能
Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):113-20. doi: 10.1055/s-0029-1202832. Epub 2009 Apr 16.
8
Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.缺氧应激通过缺氧诱导因子-1α同时刺激血管内皮生长因子,并抑制人子宫内膜基质细胞中的基质细胞衍生因子-1。
Hum Reprod. 2012 Feb;27(2):523-30. doi: 10.1093/humrep/der405. Epub 2011 Nov 28.
9
Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.格尔德霉素对前列腺癌细胞中缺氧诱导因子-1α介导的血管生成和侵袭的影响。
Prostate Cancer Prostatic Dis. 2006;9(2):126-35. doi: 10.1038/sj.pcan.4500852. Epub 2006 Jan 24.
10
Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.啮齿动物和人类垂体肿瘤细胞体外血管内皮生长因子的产生与调控
Neuroendocrinology. 2001 Aug;74(2):95-105. doi: 10.1159/000054675.

引用本文的文献

1
Ferroptosis-Regulated Natural Products and miRNAs and Their Potential Targeting to Ferroptosis and Exosome Biogenesis.铁死亡调控天然产物和 miRNAs 及其对铁死亡和外泌体生物发生的潜在靶向作用。
Int J Mol Sci. 2024 May 31;25(11):6083. doi: 10.3390/ijms25116083.
2
The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer.姜黄素对肿瘤微环境中缺氧的影响作为癌症的一种调节因子。
Arch Med Sci. 2023 Aug 14;19(6):1616-1629. doi: 10.5114/aoms/171122. eCollection 2023.
3
Reduction-responsive worm-like nanoparticles for synergistic cancer chemo-photodynamic therapy.
用于协同癌症化学-光动力疗法的还原响应性蠕虫状纳米颗粒。
Mater Today Bio. 2023 Jan 4;18:100542. doi: 10.1016/j.mtbio.2023.100542. eCollection 2023 Feb.
4
Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies.植物化学物质作为肿瘤糖酵解和缺氧信号通路的调节剂:来自体外研究的证据
Pharmaceuticals (Basel). 2022 Jun 28;15(7):808. doi: 10.3390/ph15070808.
5
Curcumin treats endometriosis in mice by the HIF signaling pathway.姜黄素通过缺氧诱导因子信号通路治疗小鼠子宫内膜异位症。
Am J Transl Res. 2022 Apr 15;14(4):2184-2198. eCollection 2022.
6
A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma.一种用于治疗葡萄膜黑色素瘤的长效姜黄素纳米颗粒/原位水凝胶复合材料
Pharmaceutics. 2021 Aug 25;13(9):1335. doi: 10.3390/pharmaceutics13091335.
7
Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.双配体修饰的载抗血管生成和化疗药物脂质体抑制肿瘤血管生成和转移。
Int J Nanomedicine. 2021 Jun 9;16:4001-4016. doi: 10.2147/IJN.S309804. eCollection 2021.
8
Hypoxia- and dexamethasone-dependent HIF1α-glucocorticoid receptor interaction leads to degradation of glucocorticoid receptor in pituitary adenomas.缺氧和地塞米松依赖性的HIF1α-糖皮质激素受体相互作用导致垂体腺瘤中糖皮质激素受体的降解。
Am J Transl Res. 2021 Feb 15;13(2):684-695. eCollection 2021.
9
Nanotechnology for angiogenesis: opportunities and challenges.纳米技术促进血管生成:机遇与挑战。
Chem Soc Rev. 2020 Jul 21;49(14):5008-5057. doi: 10.1039/c8cs01021h. Epub 2020 Jun 15.
10
Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.罗沙司他(FG-4592)作为一种口服低氧诱导因子脯氨酰羟化酶抑制剂,具有改变膜离子流的能力证据:一个尚未识别但很重要的作用。
Int J Mol Sci. 2019 Nov 29;20(23):6027. doi: 10.3390/ijms20236027.